| 000 | 01893 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250513031015.0 | ||
| 264 | 0 | _c19940815 | |
| 008 | 199408s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArneric, S P | |
| 245 | 0 | 0 |
_a(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 1994 |
||
| 300 |
_a310-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlkaloids _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
| 650 | 0 | 4 | _aAzocines |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aIon Channels _xdrug effects |
| 650 | 0 | 4 |
_aIsoxazoles _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNicotine _xmetabolism |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 |
_aParasympathomimetics _xmetabolism |
| 650 | 0 | 4 |
_aPyrrolidines _xmetabolism |
| 650 | 0 | 4 | _aQuinolizines |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xdrug effects |
| 650 | 0 | 4 |
_aRubidium _xpharmacokinetics |
| 650 | 0 | 4 | _aRubidium Radioisotopes |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aSullivan, J P | |
| 700 | 1 | _aBriggs, C A | |
| 700 | 1 | _aDonnelly-Roberts, D | |
| 700 | 1 | _aAnderson, D J | |
| 700 | 1 | _aRaszkiewicz, J L | |
| 700 | 1 | _aHughes, M L | |
| 700 | 1 | _aCadman, E D | |
| 700 | 1 | _aAdams, P | |
| 700 | 1 | _aGarvey, D S | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 270 _gno. 1 _gp. 310-8 |
|
| 999 |
_c7517981 _d7517981 |
||